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1. Introduction 
Many individuals are still hesitant to undergo colonoscopy despite numerous 
advertisements and campaigns about it. A few years back, a famous TV personality 
named Katie Kouric, had her colonoscopy broadcasted through live television because she 
wanted the public to see that there’s nothing scary or frightening about the procedure. 
Her husband died of colon cancer at a young age. Had he had a colonoscopy (Fig. 1), his 
cancer would have been diagnosed and treated early which could have saved or 
prolonged his life.  
 
 
Fig. 1. Colonoscopy.  
The test remains an uncomfortable, frightening, and embarrassing and anxiety producing 
situation, especially for people undergoing it for the first time, which can then lead to delays 
in screening and treatment. Though endoscopic procedures can be performed and tolerated 
without sedation, studies have shown that “16% to 56% of such procedures are terminated 
because of pain”.²² The goal of colonoscopy is to reach the cecum (the beginning of the large 
intestine). The scope is less likely to reach that destination, as it navigates the long and 
tortuous colon, without adequate sedation. Figure 2 shows the colon or large intestine and 
its location in the abdomen. 
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Many countries around the world commonly perform colonoscopy without sedation. ¹² In 
Japan, though endoscopic procedures are routinely carried out without sedation, many 
Japanese are now choosing this to ease the discomfort.³² Only 2%-7% would prefer this 
option in the United States.²9  
 
 
 
 
Fig. 2. The colon or large intestine 
The challenge and goal of sedation in colonoscopy is to effectively facilitate the procedure 
while relieving anxiety, pain or discomfort, providing amnesia, and preserving 
cardiopulmonary function of the individual, with minimal cognitive impairment post 
procedure. This may delay the individual’s discharge from the hospital. Sedation is now 
the standard of practice for endoscopic procedures in the U.S. and in many other 
countries. It is necessary to complete the procedure with ease and comfort.²6,¹9,²¹,²³,9,³²,³¹,³ʛ 
Currently used medications are: benzodiazepines (e.g., midazolam, diazepam), opioids 
(e.g., meperidine, sublimaze), and propofol. Ketamine and inhaled anesthetics (e.g. 
nitrous oxide) are rarely used because of their side effects and uneasiness of 
administration.²³,²² These drugs are used alone or in combination with another drug. 
Comparison studies have been done to determine which combination of drugs are better 
in minimizing cognitive impairment post procedure, but none have been found to be 
better than the other.²¹ The ideal amount of sedation for a patient undergoing colonoscopy 
has also not been established despite the many different techniques, medications and 
combinations thereof attempted.  
This chapter will discuss the different types of moderate sedation given, who will be 
administering it, and how individuals are monitored during the procedure. The goal is to 
inform the public of the different methods of making one comfortable during colonoscopy. 
Emphasis will be given to the fact that this procedure is short and safe, and usually does not 
require administration of heavy-duty anesthetics or sedatives. Monitoring is done 
frequently with particular attention to the airway, breathing (using pulse oximetry and 
capnography) and circulation i.e., heart rate and blood pressure. Knowledge of the 
availability of these medications will make the individual feel confident that he or she will 
be comfortable and cared for during his or her colonoscopy. 
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Fig. 3. Confidence and satisfaction in colonoscopic procedures 
2. Safety and efficacy of currently used sedation drugs for colonoscopy 
Sedation is defined as the calming of mental excitement or abatement of physiologic 
functions with the administration of a drug,³¹ i.e. a drug-induced depression of the 
individual’s level of consciousness.⁴ As mentioned earlier, sedation is recommended in most 
endoscopic procedures to facilitate completion of the procedure, which in this case, would 
be colonoscopy.  
Four levels characterize sedation: minimal or light (anxiolysis) sedation, moderate sedation 
(formerly known as conscious sedation), deep sedation, and general anesthesia.² The most 
commonly used in colonoscopy is moderate sedation, where the patient continues to 
respond purposefully to verbal commands, with or without light touch stimulation. He is 
spontaneously breathing on his own and may be supported with minimal amounts of 
oxygen via a nasal cannula or sometimes a mask may be necessary. In deeply sedated states, 
patients may not be roused easily, and respond only after repeated or painful stimuli. They 
may also not have spontaneous respirations (breathing on their own) requiring assistance to 
maintain a patent airway. General anesthesia is normally reserved for surgical procedures 
wherein patients do not respond to any form of stimulation, are completely immobile and 
support of his or her cardiovascular functioning is required.⁴ Table 1 shows summary of the 
various levels of sedation and analgesia. Adapted from the American Society of 
Anesthesiologists Standards and Guidelines (2009).² 
Moderate anesthesia care (MAC) and/or moderate level of sedation (also formerly known 
as conscious sedation) is usually employed during colonoscopy. It allows for better patient 
cooperation and a quicker or shorter recovery time.²6 Individuals certified to administer the 
drugs and monitor the patient’s response(s), such as a gastroenterologist, a registered nurse, 
a certified registered nurse anesthetist, or an anesthesiologist, can safely administer this.³² 
However, there are some differences between MAC and moderate sedation. During 
moderate sedation, a physician personally administers or supervises a nurse to administer 
the sedative and/or analgesic drug. These individuals are qualified and certified to 
administer the sedation drugs maintaining the level of sedation to a “moderate” or lesser 
degree. They continually monitor and assess the effects of these drugs and level of sedation 
the patient is in throughout the duration of the procedure, are competent to recognize 
changes especially when the individual goes into a deeper level than originally intended 
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and, are able to manage the consequences and adjust additional doses of the medication to 
maintain the desired level of consciousness.  
 
 
Minimal or 
Light 
Sedation 
(Anxiolysis) 
Moderate 
Sedation or 
Analgesia 
(Conscious 
Sedation) 
Deep Sedation 
or Analgesia 
General 
Anesthesia 
Responsiveness 
Normal 
response to 
verbal stimuli 
Purposeful 
response to 
verbal or 
tactile stimuli 
Purposeful 
response 
following 
repeated or 
painful stimuli 
Unarousable 
even with 
repeated or 
painful stimuli 
Airway Unaffected 
No 
intervention 
required 
Intervention 
may be 
required 
Intervention is 
often required 
Spontaneous 
Ventilation 
Unaffected Adequate 
Maybe 
inadequate or 
compromised 
Frequently 
inadequate and 
is 
compromised 
Cardiovascular 
Function 
Unaffected 
Usually 
maintained 
Usually 
maintained 
Maybe 
impaired 
Table 1. Summary of the various levels of sedation and analgesia. Adapted from the 
American Society of Anesthesiologists, Standards and Guidelines, 2009. ² 
In moderate sedation, the provider assigned to observing and monitoring the patient as well 
as administering the sedation medications has other responsibilities and tasks that are 
interruptible and of short duration. The reverse is true for moderate anesthesia care or 
MAC, where the provider (usually an anesthesiologist or nurse anesthetist) is solely 
dedicated to the observation and monitoring of the patient and does not have any other 
procedure-related responsibilities. He must be prepared to convert to general anesthesia 
when the patient’s cardiorespiratory status is compromised. It is an essential component of 
his initial assessment to evaluate the patient’s actual or anticipated physiological problem 
that may compromise his cardiorespiratory status during the scheduled procedure. His 
ability to rescue a patient whose airway is compromised is a prerequisite to his ability to 
provide moderate anesthesia care. The administration of hypnotics, sedatives and 
analgesics, as well as other drugs commonly used for the induction and maintenance of 
general anesthesia is often, but not always, a part of monitored anesthesia care.⁴  
Since sedation is a continuum, it is impossible to predict how an individual will respond to 
the drugs. Some patients may require only small amounts of sedation, but MAC is often 
indicated because even small doses of these medications could precipitate adverse 
physiologic responses that would require acute clinical interventions and resuscitation. If a 
patient’s health status or condition, or medical/surgical history is likely to require sedation 
to a deeper level or even to a momentary period of general anesthesia, then MAC is the 
preferred method. Due to the strong possibility that a deep or deeper level of sedation may 
transition to general anesthesia, the skills and expertise of an anesthesia provider (e.g. 
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anesthesiologist or certified registered nurse anesthetist, CRNA) are essential to manage the 
effects of general anesthesia as well as the patient’s quick return to a lesser state of sedation. 
MAC also includes post-procedure responsibilities such as ensuring return to full 
consciousness, complete relief of pain, management of side effects or any adverse 
physiologic responses from the drugs administered during the procedure, as well as the 
diagnosis and treatment of some co-existing medical problems.² 
Since individuals vary in their responses to the sedation medication, and may be in different 
levels of sedation as well, while undergoing the same procedure, or may require different 
levels to complete the procedure;  it is imperative that clinicians administering the 
sedatives/analgesics and monitoring their effects have the necessary skills and knowledge 
in recognizing complications associated with sedation/analgesia, and be able to rescue or 
resuscitate the individual whose sedation status is deeper than originally intended.⁴,³ʚ They 
must have also undergone a course or class and be certified in cardiopulmonary 
resuscitation (CPR) as well as in Advanced Cardiac Life Support (ACLS).²º,¹6,³ʚ,³  In patients 
with significantly sedation-related risk factors, i.e., severe obstructive pulmonary disease, 
sleep apnea, potentially difficult airway, congestive heart failure, and coronary artery 
disease, the presence of an anesthesiologist is highly recommended. It is also recommended 
for patients who may require a deeper level of sedation to achieve adequate procedure 
result, such as individuals who are on high doses of psychotropic medications, 
benzodiazepines, alcohol, and narcotics.⁴,²²,³ 
 
Class Description 
ASA I A normal healthy patient 
ASA II 
Patient has mild systemic disease which does not interfere with 
daily activities, such as high blood pressure that is under control 
ASA III 
Patient has a moderate or severe systemic disease that does not 
inhibit or limit daily activities such as diabetes with some 
systemic complications 
ASA IV 
Patient has a severe systemic disease that is a constant threat to 
life such as end-stage renal or liver failure, or congestive heart 
failure 
ASA V 
The patient is moribund and is not expected to survive  within 24 
hours, with or without the procedure 
ASA VI 
The patient is declared brain-dead and his or her organs are being 
removed for donation purposes. 
E 
In addition to indicating the ASA status, a patient undergoing an 
emergency procedure is indicated by the suffix “E.” 
Table 2. Patient status classification according to the American Society of Anesthesiologists 
(ASA) 
Many studies have been performed regarding administration of these drugs during 
colonoscopy and were found to provide safe and effective sedation during the procedure, 
especially when titrated in small incremental doses. Though safe and effective, these drugs 
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do carry potential problems or concerns that include cardiopulmonary events, such as 
hypotension, airway obstruction, hypoxia/hypoxemia, aspiration, apnea, arrhythmia, 
vasovagal episodes, and though uncommon, serious morbidity and death can also 
occur.²⁴,¹⁵,¹6 A review of data from the American Society for Gastrointestinal Endoscopy’s 
(ASGE) computer-based management system of 21,000 GI endoscopies in 1988 using Versed 
(Midazolam) and Valium (Diazepam) revealed the following: Overall complication rate was 
13.5 events per 1000 procedures and serious cardiopulmonary events were 5.4 per 1000. 
Death occurred in 0.3 per 1000.⁵ Another study evaluating the safety of the combination of 
meperidine (Demerol) with either midazolam (Versed) or diazepam (Valium) revealed no 
deaths.6 Results from two other studies showed a considerably lower incidence of 
cardiopulmonary complications using propofol as compared with the use of 
benzodiazepines during routine endoscopic procedure.³ʛ,²⁵,²ʛ  Because of these potential 
complications, endoscopy suites are equipped with the tools necessary to rescue the patient. 
These include: a suction machine, oxygen outlet or tank, a code cart with a defibrillator, a 
bag-valve mask, oral and nasal airways, a nasogastric tube, materials for respiratory 
intubation, and drugs required for cardiorespiratory resuscitation.²º 
3. Economics of sedation in endoscopy 
In the past, gastroenterologists have routinely administered the sedating agents to their 
patients as part of the colonoscopy service. However, in recent years, many endoscopists are 
employing the services of an anesthesiologist or a certified registered nurse anesthetist 
(CRNA) to administer the sedation. The influencing factors being, the increased use of 
propofol during this procedure, effective marketing by anesthesiologists, and by a decrease 
in reimbursements by insurers.⁴,³⁵  
The approach of individual countries towards administration of sedatives and analgesics 
during colonoscopy varies widely due to differences in health insurance reimbursements 
and budget restraints.⁴¹,²²  In the United States, Medicare reimbursements for use of an 
anesthesiologist during colonoscopy are not uniform across the nation. Some health insurers 
also question the separate billing of anesthesia service when generally; reimbursement fee 
for the colonoscopy includes administration of sedation under the supervision of the 
gastroenterologist.¹ 
Ideally, an anesthesiologist is present in all cases of colonoscopy to optimize sedation and 
analgesia. However, his presence during this short procedure for individuals who are at 
average-risk for developing sedation-related complications is debatable and not cost-
effective.¹ Normally, these patients are able to maintain their airway with minimal or no 
support so that the skills of an anesthesiologist is not necessary. Many studies have been 
done exploring the use of a registered nurse administering propofol and have found safety 
levels equivalent to those administered with benzodiazepines and narcotics.³²,³³,³º,³6 
4. Colonoscopy without sedation 
In some instances, few selected patients opt to undergo their colonoscopy without sedation. 
In the US, a survey found that only 2% to 7% of individuals were willing to do their 
colonoscopies without sedation.²9 Review of literature found no randomized control trials 
done to compare sedation versus no sedation during colonoscopy. Many argue that they 
want to watch the procedure and are fascinated by what’s inside the human body. Some are 
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unable to find an available designated driver and are unwilling to reschedule their 
appointment. Still some have stated that they have a lot of commitments and things to do 
that they cannot afford to skip a day to rest at home. In some rare instances, the individual 
went straight to work after his procedure. The type and level of monitoring should be 
tailored to each individual in these cases. Often, the individual is advised to bring a 
designated driver, in case he changes his mind and decides to receive sedation. Men, 
patients who are generally healthy and have no history of abdominal pain, individuals who 
are not anxious, and older patients may be better able to tolerate the colonoscopy without 
sedation. In situations like this, a smaller diameter endoscope (pediatric scope) is used and 
is better tolerated.  
5. Preprocedure assessment and monitoring 
A few weeks prior to the scheduled colonoscopy, the patient usually pays his endoscopist a 
visit to review his general state of health, medical and surgical histories, allergies, and 
regularly taken medications. Special instructions will be given to diabetics with regards to 
intake of their medications as well as diet. The appropriate bowel cleansing prep will be 
reviewed and instructions provided. The patient will also be informed that he will be 
receiving sedating medications to make the procedure more comfortable and tolerable. He is 
then advised to arrange for someone to drive him home because he will not be allowed to 
drive home, take the bus or taxi after the procedure due to the residual effects of the 
sedative; emphasizing the fact that these side effects do alter his reflexes and cognitive 
functioning. This usually wears off in about four to six hours; and, even after this time, the 
individual may still feel very tired and sleepy. Patients are discharged home and advised to 
take the day off and rest. They are normally allowed to eat light, non-spicy, and easily 
digestible foods to avoid nausea and vomiting which is often a side effect of sedatives and 
opioids. 
The use of combination regimen as well as patient characteristics influence the safety and 
choice of sedative regimens for this procedure. Therefore, general data is collected from 
every patient, recorded in his medical record and reviewed by both the endoscopist and the 
personnel providing the sedating medication (s), shortly before the colonoscopy is 
performed. These include: name, age (determined by date-of-birth), sex, general condition of 
health (as outlined in the ASA classification, Table 2), daily medications taken, allergies, 
medical and surgical histories, adverse reactions to sedatives and anesthetics, and problems 
(if any) post procedure or surgery. The following historical events should also be obtained 
from the patient: any significant abnormalities of major organ or organ systems, snoring or 
sleep apnea (using CPAP or BiPap), time and type of last meal taken, use of illicit drugs, and 
alcohol and tobacco use. Regarding the “time and type of last meal taken,” there are no 
absolute or ultimate guidelines regarding the stopping of oral intake prior to administration 
of sedatives. There are no supporting data showing a direct relationship between fasting 
time and risk of aspiration into the lungs. The ASA guidelines recommend that patients not 
have clear liquids two hours before the procedure and a light meal six hours before 
administration of any sedating medication. This would allow sufficient time for the stomach 
to adequately empty.⁴ According to the American College of Emergency Physicians, “recent 
food intake is not contraindicated for administering procedural sedation and analgesia, but 
should be considered in choosing the timing and target of sedation”.ʛ 
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Physical examination of the individual is obtained and recorded. These include, initial vital 
signs (temperature, heart rate, blood pressure, respiratory rate, and oxygen saturation), level 
of consciousness, examination of heart and lungs, and airway anatomy (using the 
Mallampati classification, Figure 4). The last one is important in situations where the 
individual may need resuscitative assistance such as: 1) individuals with a history of 
snoring, stridor, or sleep apnea and is using a CPAP or BiPAP machine, 2) neck 
abnormalities involving the neck and facial features (e.g. obese persons),  short neck, limited 
neck extension, neck mass, cervical spine disease or trauma to the neck, tracheal deviation, 
advanced rheumatoid arthritis, decreased hyoid-mental distance (<3cm in adults), 3) 
abnormalities of the mouth such as protruding incisors, small opening ( <3cm n adults), 
high arched palate, hypertrophy of the tonsils, nonvisible uvula (see class 4 of the 
Mallampati classification, Figure 4), edentulous, loose or capped teeth, macroglossia, 4) 
history of problems with sedation and anesthetics, 5) dysmorphic facial features such as 
trisomy and Pierre-Robin syndrome, and 6) jaw abnormalities such as trismus, significant 
malocclusion, micrognathia, and retrognathia. The ASA Task Force guideline states “that 
the presence of one or more sedation-related risk factors coupled with the potential for deep 
sedation will increase the likelihood of adverse sedation-related events.” Consultation with 
someone trained in managing these complex situations, usually an anesthesiologist or a 
certified registered nurse anesthetist should be considered.⁴ The presence of an 
anesthesiologist is also highly recommended for the following situations: 
 Significantly compromised individuals such as those with congestive heart failure, 
coronary artery disease, and severe obstructive pulmonary disease (COPD) on 
continuous oxygen therapy or using CPAP or BiPAP machines 
 Individuals with difficult airways (such as those described above) 
 Extremely obese individuals 
 ASA status classification of Class III, IV, and V 
 Increased risk of pulmonary aspiration 
 The individual is pregnant 
 If it appears that sedation (even with small doses) will make the patient unresponsive 
and airway will be compromised 
 General anesthesia is necessary to complete the procedure while maintaining patient 
safety and comfort 
 Unavailability of a trained practitioner to administer moderate sedation 
 Anticipated intolerance of standard sedation drugs (e.g. alcohol or substance abuse) 
 Adverse reactions to sedatives 
 Inadequate response to moderate sedation 
A Modified Aldrete score is also assigned (see post procedure monitoring). An 
intravenous access is established because sedation drugs are normally given 
intravenously. Fluids may or may not be routinely given depending on the institution’s 
procedural policies and regulations. For female patients, it is necessary to mention the 
possibility of being pregnant or is pregnant. If in doubt, a pregnancy test may be 
performed. Lactating mothers should also mention if they are breastfeeding as most of the 
medication is excreted in breast milk.  
Shortly before the procedure starts, the provider of the sedating medications will discuss 
with the patient the type of sedating medications to be given; its benefits, risks and 
complications, limitations and other alternatives. The endoscopist will also review the 
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procedure with the patient. He will then sign the consent form allowing the endoscopist to 
perform the procedure and to be given sedating medications (if agreeing to sedation). The 
anticipated level of sedation should be congruent with the expected level of sedation by the 
individual as much as possible. The endoscopist will also review the colonoscopy 
procedure, the benefits, risks and complications to patients who are not receiving sedation. 
Preparation is the same as for sedation in the event that an emergency arises or the patient 
requests medication during the procedure. 
 
 
Fig. 4. Mallampati classification of airway management. 
6. Sedation and monitoring during colonoscopy 
According to the recommendations outlined by The Joint Commission and the Association 
of Anesthesiologists, hospital-based endoscopy suites consists of the following personnel: a 
physician endoscopist, an assisting nurse, and an additional nurse solely administering 
sedatives and monitoring the patient.¹⁴ However, with the advent and increased use of 
propofol, there has been a demand for the presence of an anesthesiologist or certified 
registered nurse anesthesiologist. This is partly due to the widespread perception that the 
drug carries major complication risks and statements emphasized by the information on the 
package insert of the drug itself, recommending that only personnel trained in the 
administration of general anesthesia administer this drug. The ASA guidelines also outlined 
numerous precautions regarding the administration of propofol thereby, increasing fears of 
non-anesthetists. It is also the perception that administration of benzodiazepines and opiates 
only induce moderate level of sedation and that propofol brings the patient into a deep level 
sedation.²º Several studies though have proved that propofol can be safely administered by 
non-anesthesiologists.¹¹,³²,¹⁵,²9 
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Only 7.7% of gastroenterologists in the US administer propofol themselves without the 
assistance or presence of an anesthesiologist or nurse anesthetist (CRNA), and 68% have 
expressed interest in incorporating it in their practice given proper training and adequately 
trained staff.9 The reason for the reluctancy among endoscopists to administer propofol 
themselves, are medico legal implications of the off-label use of propofol, the potential risks 
and complications, local institutional policy, and state regulatory restrictions.⁴ Hence, 
propofol is usually administered by an anesthesiologist (or by a certified registered nurse 
anesthetist [CRNA]) which is often not cost-effective in ambulatory gastrointestinal (GI) 
suites .¹² In some countries, like Switzerland, 34% of gastroenterologists polled administer 
propofol themselves.¹⁵  
During the procedure, the patient is hooked up to a monitor that measures and displays the 
heart rate, blood pressure, and oxygen saturation (Figure 5) and in some cases, carbon 
dioxide levels (capnography). Some have also used transcutaneous carbon dioxide 
measurement or bispectral index monitoring (BIS). The latter is a quantitative assessment of 
cortical activity that has been used to monitor sedation and adjust sedation levels (Kissin, I., 
2000). These are monitored by a licensed personnel (usually the person providing the 
sedation) every 3-5minutes during the procedure and with each incremental dose of the 
sedative. Monitoring may detect changes in the individual’s blood pressure, heart rate, 
cardiac electrical activity, ventilatory, and neurologic status that might signal a clinically 
significant compromise of the patient’s health status or that the patient has progressed to a 
deeper level of sedation than originally intended. Oxygen is usually given as an adjunct via 
a nasal cannula or mask as all of the sedation agents depress the respiratory system. The 
ASA guidelines recommend that patients receiving sedation medications receive continuous 
electrocardiogram (ECG) monitoring, especially if they have significant cardiovascular 
disease or arrhythmias.²º Parameters outlined in the Modified Aldrete scoring system, 
which includes the above mentioned items plus activity and consciousness are also 
monitored and recorded. 
 
 
Fig. 5. Sample of monitoring equipment used 
In most institutions, an intravenous access is started and IV fluids are given prior and 
during the procedure. This helps hydrate the patient, provide an avenue for the 
administration of sedating drugs, and as a rescue means should the patient become 
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hypotensive (ASGE, 2008). Should the patient’s condition get compromised or deteriorate at 
any given time during the procedure, the colonoscopy is halted and resuscitative measures 
are instituted. He may need to be transferred to the Critical Care Unit or the Emergency 
Department for further management. 
6.1 Post procedure monitoring 
Upon completion of the colonoscopy, the patient is kept in the room and monitored for a 
few more minutes until he is rousable and able to maintain his airway independently. 
Shortly thereafter, he is disconnected from all the monitoring equipment and brought to the 
recovery or discharge area to allow the effects of the sedatives to wear off. Here, the same 
parameters monitored during the procedure are monitored and recorded every 10-15 
minutes for about half-an-hour to an hour, without the continuous cardiac monitoring 
(ECG) (unless warranted) and the carbon dioxide monitoring, until the patient is at or close 
to his or her baseline cognitive functioning level as possible, and is ready for discharge to 
home. Blood sugar levels of diabetics will also be checked and intervention given as 
necessary. 
At this time, the endoscopist will come to discuss his findings during the procedure, any 
interventions done (i.e. biopsies taken), and discharge and follow-up instructions will be 
given. The patient’s designated driver is encouraged to be present because he (the patient) 
may not remember what the endoscopist has said as a result of the amnesic properties of the 
sedatives, especially with benzodiazepines (not so with propofol), unless the patient 
requests otherwise. The patient is discharged when he or she has met discharge criteria as 
outlined by the Modified Aldrete or Aldrete and Kroulik scoring system (Tables 3 and 3.a) 
or whichever discharge scoring system the institution is using and has returned to his 
baseline (or close to it) level of cognitive and physiological functioning as possible.  
Ideally, the recovery or discharge area should allow rapid recovery of the sedated 
individual, with minimal or without residual physiologic, cognitive or psychomotor 
impairments. Several discharge criteria have been formulated to facilitate and guide 
clinicians to objectively asses the clinical status of the sedated patient and be able to 
discharge him home. The most commonly used is the Modified Aldrete or Aldrete and 
Kroulik scoring systems (Table 3 and 3.a).³9 The preferred method is the Modified Aldrete 
scoring system as most institutions do not use arterial pressure monitoring for endoscopy 
procedures, especially in an outpatient setting. This scoring is also used pre-, inta and post 
procedure. During the procedure, if the patient is maintained at the moderate sedation level, 
his score should be a 9 or a 10 or whatever his baseline score was at the start. Over sedation 
is defined by a score of less than 9 and corrective action should be initiated. All post 
sedation patients should have their vital signs back to within 10% of their baseline score or 
be admitted to the hospital for further evaluation especially if corrective/resuscitative 
actions have failed to improve his score or condition.  
Post anesthesia discharge scoring system (PADSS) has been developed for post-anesthesia 
care units in Canada. This allows the health care providers to monitor the patient’s 
readiness to be discharged home. The average length of time the sedated patient stays in the 
discharge or recovery area is half-an-hour to an-hour depending on the kind and amount of 
sedation drugs received during the procedure. Patients who receive propofol generally 
recover quicker and are discharged home in a much shorter time than those who receive 
benzodiazepines or in combination thereof.²º Prompt and safe discharge of the patients 
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reduces the amount of time they stay in the discharge area and contributes to cost reduction 
and unit efficiency.ʚ 
 
Modified Aldrete Scoring 
Criteria Ability Score 
Activity 
Ability to move voluntarily or on command: 
Four extremities 
Two extremities 
No movement 
 
2 
1 
0 
Respiration 
Able to cough and breathe deeply freely 
Dyspnea, shallow or limited breathing 
Apnea 
2 
1 
0 
Circulation 
Blood pressure within 20mm Hg of  pre-sedation level 
Blood pressure within 20-50mm Hg of pre-sedation level 
Blood pressure + 50mm Hg of pre-sedation level 
2 
1 
0 
Consciousness 
Fully awake 
Arousable on calling 
Not responding 
2 
1 
0 
O2 Saturation 
Able to maintain O2 saturation >92% on room air 
Needs O2 to maintain O2 saturation >90% 
O2 saturation is <90% even with O2 supplementation 
2 
1 
0 
Table 3. Modified Aldrete Scoring System 
 
Assessment Item                 Condition                                                        Grade 
                                               Moves 4 extremities                                               2 
Muscle Activity                     Moves 2 extremities                                               1 
                                               Moves 0 extremities                                               0 
                                                   Deep, Cough                                                           2 
Breathing                              Limited, Dyspnea                                                   1 
                                                  Apnea                                                                       0 
                                                Fully awake                                                             2 
Consciousness                     Awakens when called                                             1 
                                             Does not respond to call                                         0 
                                             + of 20% of pre-anesthesia level                             2 
Circulation (AP)*                 + 20% to 49% of pre-anesthesia 
                                                level                                                                         1 
                                             + 50% of pre-anesthesia level                                 0 
                                             Maintains SpO2 >92% in ambient air                     2 
SpO2**                                  Maintains SpO2 > 90% with O2                             1 
                                             Maintains SpO2 <90% with O2                               0 
*AP = arterial pressure  
** = peripheral oxygen saturation 
Table 3a. Aldrete and Kroulik Index 
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7. Commonly used sedation agents 
Colonoscopy procedures are usually done under moderate level of sedation or moderate 
anesthesia care (MAC). To achieve this, general practice guidelines call for the careful 
titration of the chosen sedative using incremental doses. The most commonly used agents 
are benzodiazepines, alone or in combination with an analgesic, and propofol, alone or also 
in combination with another agent.²¹,²6,²²  The choice of sedating agent is largely dependent 
on the provider based on what he thinks and feels is the best in maximizing patient comfort 
at the same time, minimizing risks and complications. A US survey noted that over 85% of 
endoscopists use or prefer to use midazolam over diazepam. Only 10% have indicated 
preference for using diazepam.9  
7.1 Benzodiazepines 
The two most commonly used benzodiazepines are midazolam (Versed) and diazepam 
(Valium). Midazolam (Versed) is also classified as an anesthetic adjunct and as a short or 
intermediate acting hypnotic. It depresses subcortical levels in the Central Nervous System, 
may potentiate -aminobutyric acid (GABA), and may act on the limbic system and reticular 
formation. It is used for preoperative sedation, anxiety, intubation procedures, induction of 
general anesthesia, and for diagnostic endoscopic procedures. It can also be used for 
refractory status epilepticus. For moderate sedation or conscious  
sedation during endoscopic procedures such as colonoscopy, midazolam can be used alone 
or in combination with a narcotic (e.g. an analgesic like meperidine or fentanyl). It is 
administered immediately prior to the procedure and supplemented by small incremental 
doses throughout until the desired effect is achieved to complete the procedure.²¹ 
Usual dosing for a healthy adult below 60 years of age range from 1mg to 2.5mg titrated 
slowly (within 2 minutes). Allow a 2-3 minute interval or more before administering any 
additional doses, and after each incremental dose to fully evaluate the desired sedative 
effect. A total dose greater than 5mg is usually not necessary and patients given an 
additional narcotic may only require 30% less of this drug, because of the cumulative CNS 
depressant effect (Product Info midazolam hcl injection, 2005). Patients 60 years and older, 
chronically ill, debilitated or with renal or hepatic insufficiency will require less, 1mg to 
1.5mg titrated slowly intravenously (maximum infusion rate is 0.75mg/min). Again, allow 2 
or more minutes before each additional dose to evaluate the desired sedative effect. A total 
dose of greater than 3.5mg is not necessary and individuals will normally require 50% less 
than what a normal healthy adult would receive especially if a narcotic were also added. An 
elderly patient should not receive a dose of more than 1.5mg. The peak effect of the drug 
may take longer and the danger of apnea or hypoventilation is greater. Metabolites of 
midazolam can accumulate in patients with renal and hepatic failure and may prolong the 
sedative effect. Administration of midazolam is contraindicated in patients with 
hypersensitivity to any component of the drug, hypersensitivity to midazolam, acute 
narrow-angle glaucoma, untreated open-angle glaucoma, pregnancy, and status 
asthmaticus.³²  
Midazolam is 97% protein bound; has a half-life of 1.8-6.4 hours; metabolized in the liver; 
excreted in the urine; and crosses the placenta and blood-brain barriers. Given 
intravenously, it has an onset of 1-5min, for a duration of 1-3 hours. Side effects of the drug 
include: headache, anxiety, insomnia, retrograde amnesia, euphoria, confusion, agitation, 
paresthesia, slurred speech, agitation, chills, arrhythmias, nausea, vomiting, hiccups, 
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increased salivation, urticaria, swelling and/or itchiness at injection site, and coughing. 
Serious adverse effects of the drug include: apnea, cardio-respiratory arrest (occurs usually 
in combination with a narcotic), oxygen desaturation, hypotension, respiratory depression, 
respiratory obstruction, bronchospasm and laryngospasm. Unopened vials are stored at 
room temperature (between 68-77 degrees Fahrenheit or 20-25 degrees Celsius) and are 
stable up to 36 days. Protect from light.³² Over sedation can be reversed with the 
administration of 0.2 mg IV flumazenil (Romazicon, Anexate). 
Diazepam (Valium) works similarly as midazolam. It is a member of the following classes: 
antianxiety, anticonvulsant, benzodiazepine, and long-acting skeletal muscle relaxant. It 
potentiates the actions of -aminobutyric acid (GABA), especially in the limbic system and 
reticular formation; enhances presympathetic inhibition, and inhibits spinal polysynaptic 
afferent paths. It is used for anxiety, acute alcohol withdrawal, as an adjunct in seizure 
disorders; as a relaxant both preoperatively and general skeletal muscle relaxation (adjunct 
for skeletal muscle spasm). Given rectally, it is used in acute repetitive (refractory) seizures. 
Other uses of diazepam are: for agitation, benzodiazepine withdrawal, chloroquine 
overdose, insomnia, and as seizure prophylaxis.³²  For sedation during endoscopic 
procedures, a dose of 10 mg or less is given intravenously prior to the procedure for a 
maximum dose of 20 mg. Patients 60 years and older, chronically ill, debilitated or with 
hepatic insufficiency will require less. There are no specific dose adjustments in patients 
with renal insufficiency. Due to the irritating nature of the drug, administration must be 
done slowly, no faster than 5mg/min., and if given through IV infusion tubing, give as 
close to the IV insertion site as possible. Do not inject into small veins (irritating and may 
cause phlebitis) or through intravenous sets made of polyvinyl chloride (PVC). Diazepam 
binds to polyvinyl chloride.³² 
Contraindications to its administration are severe hepatic insufficiency, hypersensitivity to 
diazepam, myasthenia gravis, acute narrow-angle glaucoma, severe respiratory 
insufficiency, sleep apnea, and children less than 6 months of age. Diazepam is 99% protein 
bound (and significantly greater in males than in females), metabolized extensively in the 
liver and excreted in the urine. It is excreted in breast milk, crosses the placenta and blood-
brain barriers. It has a half-life of 30-60 hours. Given intravenously, it has an immediate 
effect and has a duration of about 15 minutes to an hour. Side effects are similar to 
midazolam and include: dizziness, drowsiness, confusion, headache, anxiety, tremors, 
stimulation, fatigue, depression, insomnia, hallucinations, ataxia, hypotension, ECG changes 
and tachycardia. Some, especially for prolonged users, experience blurred vision, tinnitus, 
mydriasis, nystagmus, constipation, dry mouth, nausea, vomiting, diarrhea, anorexia, 
neutropenia, rash, dermatitis, and itching. Injectable diazepam can be stored at room 
temperature and has been found to maintain stability up to 5 months; otherwise, store at 
temperatures 25 degree Celsius (77̊ F) or lower to prevent deterioration. 
Both diazepam and midazolam are similar in producing effective sedation prior to short 
surgical as well as endoscopic procedures. However, midazolam produced a greater degree 
of amnesia, lesser pain on injection, and lesser phlebitis at injection site than diazepam. It 
also produced a greater respiratory depression than diazepam during the first 45minutes of 
administration, though the latter sustained the effects longer than midazolam after an hour 
of administration. Midazolam was also more acceptable to patients than those given 
diazepam. Hence, midazolam is now the agent of choice when amnesia and adequate 
sedation is required. One disadvantage, though, noted with the administration of 
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benzodiazepines is that since they are fat-soluble (particularly diazepam), repeated dose 
results in accumulation of the drug in the adipose tissues which is subsequently released 
into the bloodstream resulting in prolonged effects. Hence, the most common reasons for 
missing work were feeling weak and drowsy or having abdominal cramping and bloating.²²  
Over sedation can be reversed with the administration of 0.2mg IV flumazenil (Romazicon, 
Anexate). 
7.2 Opiates 
The sedative and amnesic effects of benzodiazepines often times do not provide adequate 
comfort for patients undergoing endoscopic procedures, especially if the procedure lasts 
longer than half-an-hour. For this reason, opiates are often added to achieve optimum 
sedation and analgesia. Very few studies have been done to evaluate the efficacy of adding 
an opiate prior to colonoscopy and authors have casted doubt on its benefit.ʛ,¹º,¹ʚ The two 
commonly used opiates are meperidine (Demerol) and fentanyl.  
Meperidine (Demerol) is an analgesic, anesthetic adjunct, and is an opioid. It is indicated as 
an anesthetic adjunct, for obstetrical pain, and as premedication for a procedure. It 
depresses pain impulses at the spinal cord level by interacting with opioid receptors. For 
endoscopic procedures, meperidine is dosed as follows: initial bolus of 25mg (given slowly) 
and subsequent incremental doses of 25mg every 2-3 minutes until the desired effect is 
achieved. Colonoscopy is usually started two to three minutes after the initial bolus of 
meperidine and midazolam and titration delivery was given every three minutes thereafter 
with meperidine 25mg and midazolam 1mg until the desired sedation effect was achieved, 
i.e. ptosis, slurred speech, and sleep. See Table 2 for dosing guidelines. 
Meperidine is readily absorbed and crosses the blood-brain and placental barriers. It is 65-
80% protein bound, metabolized in the liver and excreted in the kidneys. It has an 
elimination half-life of 3.2-3.7 hours. It is contraindicated in individuals with 
hypersensitivity to meperidine and those who are taking MAOI (monoamine oxidase 
inhibitor) drugs. Use with caution in individuals with low blood volume, receiving 
concomitant CNS depressants (reduce dosage), head injury, impaired respiratory function, 
acute abdominal conditions, Addison’s disease (reduce dosage), elderly, debilitated, 
hypothyroidism, prostatic hypertrophy and urethral strictures, seizures (may induce more), 
severe hepatic and renal impairment, cardiac dysrhythmias such as SVTs and A-flutter. Side 
effects include: CNS: drowsiness, dizziness, confusion, headache, sedation, euphoria, 
increased intracranial pressure, seizures and serotonin syndrome; CV: palpitations, 
bradycardia, hypotension and orthostatic hypotension, tachycardia; EENT: tinnitus, blurred 
vision, miosis, diplopia, depressed corneal reflex; GI: nausea, vomiting, anorexia, 
constipation, cramps, biliary spasm, and paralytic ileus; GU: urinary retention, dysuria; 
Integ: rash, urticarial, bruising, flushing, diaphoresis, xerostomia and pruritus. Adverse 
effects include respiratory depression, cardiac arrest and anaphylaxis. Use judiciously when 
used in conjunction with benzodiazepines because of its added CNS and respiratory 
depressant effects.³² 
The other opioid of choice is fentanyl which shares the same classification as meperidine: 
analgesic, anesthetic adjunct, and opioid. It acts by inhibiting the ascending pain pathways 
in the CNS (central nervous system), increases pain threshold, and alters pain perception by 
binding to opioid receptors. It is used to control moderate to severe pain, as an adjunct to 
general and regional anesthesia, and premedication for procedures requiring conscious 
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sedation, such as colonoscopy. Compared to meperidine, fentanyl has a more rapid onset of 
action and clearance. It also has a lesser incidence of nausea than meperidine. 
For procedural sedation, the suggested doses are 0.5 to 1.5mcg/kg intravenously and 
repeated every 1 to 3 minutes until the desired sedative effects is achieved. Administer 
slowly to prevent rigidity. It is metabolized by the liver, excreted in the kidneys and breast 
milk and crosses the placenta. Given intravenously, its onset is immediate, within a minute, 
peaking in 3-5 minutes for ½-1 hour. It has a half-life of 1 ½-6 hours and is 80% bound to 
plasma proteins. Side effects are similar to meperidine and include: dizziness, delirium, 
bradycardia, hypo/hypertension, blurred vision, miosis, nausea, vomiting, constipation, 
urinary retention, rash, diaphoresis, muscle rigidity, cardio-respiratory depression and/or 
arrest, and laryngospasm. It is contraindicated in individuals with myasthenia gravis and 
those with hypersensitivity to opiates, bronchial asthma, paralytic ileus, situations of 
significant respiratory distress.³² 
Opioids and benzodiazepines combined work synergistically. Antagonists of these 
medications are naloxone (Narcan) for opiates (typical dose is 40-400mcg IV) and flumazenil 
(Romazicon) for benzodiazepines (typical dose is 40-400mcg IV). These drugs should be 
readily available in every GI suite to rescue a patient who has been given too much sedative 
and whose cardiorespiratory status is compromised. 
7.3 General anesthetic 
The only drug used in colonoscopy in this category is propofol (Diprivan). It produces a 
dose-dependent CNS depression by activating the GABA receptors. Its principal uses are for 
the induction and maintenance of anesthesia and sedation in mechanically ventilated 
patients. It also potentiates the effects on the central nervous system of analgesics and 
sedatives such as benzodiazepines and barbiturates. It has a rapid onset of sedation, but also 
marked cardio-respiratory depressant properties. These side effects usually rapidly 
diminish or reverse with reduction of dose or stopping of administration or infusion of 
propofol. There has been an increase in its use in endoscopic procedures because of its rapid 
onset and faster recovery to alertness properties with minimal residual sedative effects, 
which makes it an attractive alternative to the longer half-life benzodiazepines.²²,¹¹ Do not 
use within 10 days of intake of monoamine oxidase inhibitors (MAOI). This drug potentiates 
CNS depression in individuals taking antipsychotic drugs, opioids, skeletal muscle 
relaxants, St. John’s wort and alcohol.³²  
Propofol may be used alone or in combination with other agents such an opioid or 
benzodiazepine. When used alone, higher doses are often required to achieve the desired 
sedation level which increases the risks of dose-related side effects such as hypotension, 
respiratory depression, and bradycardia. In combination with other agents, the clinician can 
adjust the dosages which usually results in administration of smaller dosages of each of the 
agents to achieve moderate sedation level. If necessary, the effects of the opioid and 
benzodiazepine can be reversed with naloxone and flumazenil. Propofol does not have an 
antidote or reversal agent as its half-life is short and the effects wear off as soon as the 
infusion of the drug is stopped.9  
Though theoretically, propofol in combination with an opioid or benzodiazepine will 
decrease the rapid recovery benefit seen with administration of propofol alone, a 
randomized control trial proved otherwise. The results showed a shorter recovery time with 
the combination regimen than the propofol alone.³⁵  
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The drug is highly lipophilic. There are two preparations that exist on the market. One is 
prepared as an oil/water emulsion (Diprivan) consisting of 1% propofol, 10% soybean oil, 
2.25% glycerol, 1.2% egg lecithin and the antimicrobial agent, EDTA. This preparation is 
contraindicated in individuals with propofol, soy or egg hypersensitivities or allergies. The 
other generic preparation has bisulfites (sodium metabisulfite) as the antimicrobial agent 
and is therefore, contraindicated in individuals with hypersensitivity or allergy to 
bisulfites.⁴,³²  
Propofol is notorious for being painful at the injection site, often described as a burning 
sensation. Several approaches have been employed to minimize this discomfort. One is the 
administration of 1-2 ml of 1% lidocaine prior to injecting propofol or mixing lidocaine and 
propofol in the same syringe. Another approach is diluting propofol in a 5% glucose 
solution. A study found that there was less pain at the injection site in individuals given the 
generic propofol (bisulfite-containing propofol) than those given Diprivan.³²  
Propofol is a category B drug and should be used with caution in lactating mothers as it is 
excreted in breast milk. It is 98% plasma-protein bound, is metabolized primarily in the 
liver, and excreted in the kidneys. Usual time from injection to onset of sedation is anywhere 
from 13-30 seconds and the duration is about 4-8 minutes.⁴ Table 4 shows a summary of 
commonly used drugs in colonoscopy. 
 
Drug 
(Trade 
Name) 
Class Effects 
Dosing 
Guidelines 
Onset/
Peak 
Duration/
Half-life
Adverse Effects 
Meperidine 
(Demerol) 
Opioid 
Anesthetic 
adjunct 
Analgesic 
Sedation
Anal-
gesia 
Bolus 25mg 
slowly  and 
incremental 
doses of 25 mg 
every 2-3 min. 
titrated to 
effect 
5 min./
Peaks in 
10 min.
2-4 hrs. /
Half-life 
of 3-5 hrs.
Respiratory 
depression, 
seizures, 
hypotension, 
nausea, vomiting 
tachycardia, and 
hypoventilation, 
SVTs 
confusion,  
euphoria 
Midazolam 
(Versed) 
Benzodia-
zepine 
Anesthetic 
adjunct 
Short or 
intermediate 
hypnotic 
Sedation
Amnesia
Anxi-
olytic 
Bolus 0.5-2mg 
with 
incremental 
doses of 2-5mg 
every 2-3 min 
titrated to 
effect 
1-5 
min./ 
Peaks in 
3-5 min.
1-3 hrs. /
Half-life 
of 1.8-6.4 
hrs. 
Apnea, 
hypotension, 
hypoventilation, 
cardiac 
arrhythmias 
(PVCs), 
bronchospasm, 
anxiety, 
laryngospasm, 
dyspnea, 
respiratory 
depression, 
headache,  
agitation 
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Drug 
(Trade 
Name) 
Class Effects 
Dosing 
Guidelines 
Onset/
Peak 
Duration/
Half-life
Adverse Effects 
Diazepam 
(Valium) 
Benzo-
diazepine 
Antianxiety
Anticon-
vulsant 
Long-acting 
skeletal 
muscle 
relaxant 
Amnesia
Anxi-
olytic 
Sedation
Bolus slowly 
2.5-10mg IV, 
maximum of 
20mg (Do not 
mix or dilute 
w/other drugs 
or solutions in 
syringe)* 
1-5 
min./ 
Peaks in 
8 min. 
15 min. to
1 hr./ 
Half-life 
30-60 hrs 
and 
increases 
with age 
and 
obesity 
(79-95 
hrs.) 
Cardiac 
dysrhythmia, 
tachycardia, 
vasculitis, 
hypotension,  
respiratory 
depression, 
confusion, 
thrombophlebitis, 
ataxia, 
hallucination, 
tremors, 
confusion, fatigue, 
dizziness 
Fentanyl 
(Sublimaze, 
Fentanyl) 
Opioid 
Anesthetic 
adjunct 
Analgesic 
Analgesia
Sedation
Bolus with 50-
100mcg. Or 
0.5-1.5mcg/kg 
per dose. 
Additional 
doses at 0.5-
1mcg/kg per 
dose titrated 
to effect** 
<1 min/ 
Peaks in 
3-5 min. 
for ½-
1hr 
30-
60min./
1.5-6 
hours 
 
Respiratory 
depression, 
hypoventilation, 
decrease in tidal 
volume, muscle 
rigidity, delirium, 
rash, blurred 
vision, miosis, 
bradycardia, 
diaphoresis, 
laryngospasm 
Propofol 
(Diprivan, 
Fresenius, 
Propoven) 
Ultra short-
acting 
hypnotic 
and sedative
Amnesia
Hypnotic
Sedation
Initial bolus of 
10-60mg; 
Additional 
doses titrated 
to level of 
sedation 
required every 
20-30 seconds, 
0.1-0.2 
mg/kg/min 
13-30 
sec/ 
 
4-8 min./
1-8 min.
 
Respiratory 
depression, 
hypoventilation, 
apnea seizures, 
hypotension, 
bradydysrhythmias, 
hives, flushing, 
phlebitis, burning 
at injection site, 
cough, hiccups, 
asystole 
*Drug is irritating to the vein, administer slowly  
**Administer slowly to prevent rigidity 
Table 4. Commonly used sedation drugs in colonoscopy 
8. Adjuncts to sedation in colonoscopy 
There are several adjuncts to the combination of benzodiazepines and opiates. Among these 
are: Droperidol, promethazine, and diphenhydramine. These medications potentiate the 
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action of the combined benzodiazepine and opiate and the result may be a deeper level of 
sedation. Adjuncts are employed when the first-line of sedatives fail to produce the desired 
level of sedation. 
Diphenhydramine, better known as Benadryl, acts on the GI tract, blood vessels, and 
respiratory system by competing with histamine for H-1 receptor sites, thereby decreasing 
histamine’s actions. It is usually used for allergy symptoms, rhinitis, motion sickness, 
nonproductive cough, antiparkinsonism, insomnia in children, infant colic, and for 
nighttime sedation. Effects are heightened in individuals taking MAOIs. Side effects include 
dizziness, drowsiness, anxiety, fatigue, euphoria, confusion, seizures, blurred vision, 
hypotension, blurred vision, urinary retention, hemolytic anemia, thrombocytopenia, 
agranulocytosis, chest tightness, wheezing, and anaphylaxis. Dose is 10-50mg IV. It is 
metabolized in the liver and excreted by the kidneys. It crosses the placenta and is excreted 
in breast milk. Its onset is immediate when given IV and the duration is 4-7 hours.³² 
Promethazine (Phenergan) acts the same way as diphenhydramine. Its uses are also similar to 
diphenhydramine. In addition, it is also used to counteract nausea and for preoperative and 
postoperative sedation. Side effects are the same as diphenhydramine with the addition of 
neuroleptic syndrome, neuritis and paresthesia, Dose is 12.5mg-50mg IV. Its onset is 3-5 
minutes with duration of 4-12 hours. It is metabolized in the liver and excreted in the 
kidneys and GI tract.³² 
Dropeidol (Inapsine) is a neuroleptic agent acting on the subcortical level producing sleep 
and tranquilization. It is used as premedication prior to surgery and induction and 
maintenance of general anesthesia. It is also used as an antiemetic postoperatively. It is also 
sometimes used for anxiety and for difficult to sedate individuals undergoing therapeutic 
endoscopy. However, this drug carries a black box warning from the Food and Drug 
Administration (FDA) warning users that it can prolong the QT interval and should be 
avoided in individuals with congestive heart failure (CHF), bradycardia, on diuretics, has 
cardiac hypertrophy, hypokalemia, hypomagnesemia, and are on drugs that normally 
prolong the QT interval. It is contraindicated in males whose QT intervals are >440msec. or 
for females whose QT intervals are > 450msec. Individuals over the age of 65, history of 
alcohol abuse, and use of benzodiazepines and opiates are also at risk. Side effects include 
seizures, neuroleptic malignant syndrome, torsade de pointes, prolonged QT interval, 
tachycardia, hypotension, hallucination, depression, extra pyramidal symptoms (EPS), 
laryngospasm, bronchospasm, chills, and sweating. Initial dose should start at 1.25mg IV. 
May give an additional 1.25mg IV dose to max of 2.5mg. Its onset is 3-5 min, peaking in ½ 
an hour and duration of 3-6 hours. It is metabolized in the liver, excreted in the urine and 
crosses the placenta. It has a half-life of 2-3 hours.³²  
The long duration of actions of these adjuncts make it a less ideal drug for use in short 
procedures such as colonoscopy. Recovery will take a longer time and will not be cost 
effective for the GI unit. 
9. Conclusion 
Colonoscopy remains the gold standard in diagnosing gastrointestinal disorders. The test 
itself along with the preparation is anxiety provoking and frightening for most people. In 
many countries around the world, colonoscopy is commonly performed without sedation. 
The discomfort hampers completion of the test; hence, sedation is now the standard practice 
in endoscopic procedures, particularly colonoscopy. Benzodiazepines, opiates, and propofol 
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are the commonly used sedating agents. Alone or in combination, many of these agents 
have been employed to maximize patient comfort and patient and physician satisfaction, but 
none have proved ideal. The widespread variation in sedation practices are also influenced 
by physician experience and expertise, financial and regulatory constraints, patient 
expectations and satisfaction, and lack of consensus on the ideal sedating agent for 
colonoscopy. More controlled clinical trials are needed to evaluate the safety and efficacy of 
the ideal sedating agent (s). 
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